Latest Updates

With the U.S. Congress on recess until October 14th, now is the perfect time to reach out and advocate for critical issues impacting your pharmacy. Access resources to aid you in the process of advocating for your pharmacy.

With most of the 2019 state legislative sessions complete, state lawmakers are beginning to look toward legislative priorities for 2020, including new drug pricing legislation.

Strong bipartisan support from the powerful Senate Finance Committee indicates that DIR fee reform remains a priority issue in the ongoing drug pricing debate.

The National Community Pharmacists Association (NCPA) recently issued a call to action to urge pharmacists to ask U.S. Senators on the Senate Finance Committee to sign onto a bipartisan letter addressed to HHS and CMS asking the Administration to revive DIR fee reform for plan year 2021. Take action immediately and urge your Senator to join their committee colleagues as a signatory on this letter.